TGen investigators devise faster, cheaper way of analyzing the human genomeSeptember 15, 2008Investigators at the Translational Genomics Research Institute (TGen) today announced a faster and less expensive way for scientists to find which genes might affect human health. Using bar-codes, not unlike what shoppers find in grocery stores, TGen researchers found a way to index portions of the nearly 3-billion-base human genetic code, making it easier for scientists to zero in on the regions most likely to show variations in genetic traits. The findings were published today in the online version of the journal Nature Methods. The study will be published in print in the journal's October edition.
Dr. David Craig, associate director of TGen's Neurogenomics Division, said the new method should cost only one-tenth, or less, of the current cost of sequencing genes commonly done to analyze Single Nucleotide Polymorphisms (SNPs), and in performing Genome-Wide Association (GWA) studies. "Our goal is to find the genetic basis of disease,'' said Craig, the study's lead author. "It (the new method) provides us a way to immediately use next-generation sequencing technology for studying hundreds to thousands of individuals.'' John Pearson, the head of TGen's Bioinformatics Research Unit, said the new method would allow scientists worldwide to more easily tune their sequencing experiments, and conduct their experiments with greater speed. "In many cases, rather than sequencing the whole genome for 10 people, researchers would rather sequence a dozen genes for 1,000 people,'' said Pearson, who contributed to the study. TGen scientists adapted an exciting new technology known as "next generation sequencing'' to allow samples to be run and analyzed using 15 well-characterized indexes. "Moving forward, TGen scientists are now attempting to merge this indexing approach with sequence-capture methods currently under development in their laboratories, which would likely further improve the cost savings and speed,'' said Dr. Matthew Huentelman, an investigator in TGen's Neurogenomics Division, who also contributed to the study. Depending on assumptions made in an experiment, the desired coverage -- and as a consequence, the cost -- can vary substantially, the study said, depending on whether the objective is: * Discovering genetic variants for genotyping by a separate method such as custom SNP genotyping. * Conducting polymorphism discovery and variant calling within one sequencing experiment. * Exhaustively resequencing for all common and rare variants. The new method of analyzing human genetics should enable scientists at TGen and elsewhere to push ahead with key scientific research needed to prevent, diagnosis and treat a variety of diseases and conditions. "Although whole-genome sequencing may be the primary motivator for improvements in sequencing technology,'' the study said, "it is clear that next-generation technologies are immediately useful for focused, hypothesis-driven sequencing of linkage peaks, groupings of candidate genes or sequencing the entire known coding sequence of the human genome.'' The Translational Genomics Research Institute | |||||||||||||||||||||
|
Related Human Genome Current Events and Human Genome News Articles Ice beetles impacted by climate change In the summer of 1968, Dave Kavanaugh set off on a hike that would change the course of his life. As a second-year medical student at the University of Colorado, he had joined a climbing club with a few members of the biophysics department, and the group had set their sights on Gray's Peak-the ninth highest mountain in Colorado. Bipolar disorder genes, pathways identified by Indiana University neuroscientists Neuroscientists at the Indiana University School of Medicine have created the first comprehensive map of genes likely to be involved in bipolar disorder. Systems biology brings hope of speeding up drug development Almost every day brings news of an apparent breakthrough against cancer, infectious diseases, or metabolic conditions like diabetes, but these rarely translate into effective therapies or drugs, and even if they do clinical development usually takes well over a decade. Washington University scientists first to sequence genome of cancer patient For the first time, scientists have decoded the complete DNA of a cancer patient and traced her disease - acute myelogenous leukemia - to its genetic roots. DNA chunks, chimps and humans Researchers have carried out the largest study of differences between human and chimpanzee genomes, identifying regions that have been duplicated or lost during evolution of the two lineages. Gene variations alter risk of esophageal cancer Variations in a common gene pathway may affect esophageal cancer risk, a dangerous and rapidly increasing type of cancer, according to research by scientists at The University of Texas M. D. Anderson Cancer Center. Consumer not ready for tailor-made nutrition In the near future it will be possible to customise the food we eat to individual needs, based on the genetic profile of the individual. 'Junk' DNA proves functional In a paper published in Genome Research on Nov. 4, scientists at the Genome Institute of Singapore (GIS) report that what was previously believed to be "junk" DNA is one of the important ingredients distinguishing humans from other species. Penn Scientists Show How Body Determines Optimal Amount of Germ-Fighting B Cells Researchers at the University of Pennsylvania School of Medicine can now explain how the body determines whether there are enough mature B-cells in the blood stream at any one time. These are the cells that produce antibodies against germs to fight infections. Candidate markers for gastric cancer The sequencing of the human genome has opened the door for proteomics by providing a sequence-based framework for mining proteomes. More Human Genome Current Events and Human Genome News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||